Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumor, Adult × FCN-437c × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1 Advanced Breast Cancer 1

Interventions

pembrolizumab 2 Ipilimumab 2 Blood Specimen Collection 2 spartalizumab 1 necitumumab 1 leronlimab 1 Watchful Waiting 1 Tomography, X-Ray Computed 1 Therapeutics 1 Surveys and Questionnaires 1 Radiotherapy 1 Radiation 1 Positron-Emission Tomography 1 PankoMab-GEX 1 Panitumumab 1 Nivolumab 1 Magnetic Resonance Imaging 1 MEK inhibitor I 1 Jupiter 1 Interleukin-2 1 Immune Checkpoint Inhibitors 1 GAT 1 Fluorodeoxyglucose F18 1 FCN-437c 1 EBI-005 1 Cyclophosphamide 1 Cetuximab 1 Celecoxib 1 CS-1003 1 Aspirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03951116 2022-03-16

FCN-437c

Fochon Pharmaceuticals, Ltd.

Phase 1 Completed

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡